You have 9 free searches left this month | for more free features.

Tesamorelin

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COPD (COPD) Trial (Tesamorelin, Placebo)

Terminated
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Tesamorelin
  • Placebo
  • (no location specified)
Mar 9, 2022

Peripheral Nerve Injuries Trial in Baltimore (Tesamorelin 2 Milligrams (MG), Placebo)

Recruiting
  • Peripheral Nerve Injuries
  • Tesamorelin 2 Milligrams (MG)
  • Placebo
  • Baltimore, Maryland
    Sami Tuffaha
Dec 7, 2021

HIV Lipodystrophy Syndrome, Growth Hormone Deficiency, Body Composition Trial in New York (Tesamorelin)

Recruiting
  • HIV Lipodystrophy Syndrome
  • +2 more
  • Tesamorelin
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University
Jul 12, 2021

Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)

Completed
  • Lipodystrophy
  • HIV Infections
  • Tesamorelin
  • Placebo for Tesamorelin
  • Birmingham, Alabama
  • +46 more
Sep 16, 2022

Human Immunodeficiency Virus (HIV), Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis (NASH) Trial in

Completed
  • Human Immunodeficiency Virus (HIV)
  • +2 more
  • tesamorelin
  • Placebo
  • Bethesda, Maryland
  • +1 more
Jan 13, 2020

Growth Hormone Dynamics and Cardiac Steatosis in HIV

Completed
  • Human Immunodeficiency Virus
  • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 18, 2022

    Mild Cognitive Impairment Trial in Galveston (Growth Hormone Releasing Hormone (GHRH), Placebo Growth Hormone Releasing Hormone)

    Completed
    • Mild Cognitive Impairment
    • Growth Hormone Releasing Hormone (GHRH)
    • Placebo Growth Hormone Releasing Hormone
    • Galveston, Texas
      The University of Texas Medical Branch
    Nov 1, 2019

    Sleep Disorder, Traumatic Brain Injury Trial (Tesamorelin, Placebo)

    Withdrawn
    • Sleep Disorder
    • Traumatic Brain Injury
    • Tesamorelin
    • Placebo
    • (no location specified)
    Nov 16, 2019

    HIV Subjects Exposed to EGRIFTA®

    Terminated
    • HIV
    • Tesamorelin for injection
    • Bakersfield, California
    • +30 more
    Sep 10, 2018

    HIV, HIV Lipodystrophy Trial in Boston (tesamorelin, )

    Completed
    • HIV
    • HIV Lipodystrophy
    • tesamorelin
    • placebo
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 28, 2017

    Egrifta Replacement and Sleep Disordered Breathing

    Withdrawn
    • Lipodystrophy
    • Tesamorelin (Egrifta)
    • Baltimore, Maryland
      Johns Hopkins Sleep Disorders Center
    Mar 2, 2017

    Adiposity and Airway Inflammation in HIV-Associated Airway

    Completed
    • Asthma
    • +2 more
    • Blood draw
    • +7 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Oct 11, 2017

    Abdominal Obesity Trial in Boston (Tesamorelin, Placebo)

    Withdrawn
    • Abdominal Obesity
    • Tesamorelin
    • Placebo
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 23, 2014

    HIV Trial in Montreal (Tesamorelin)

    Completed
    • HIV
    • Tesamorelin
    • Montreal, Quebec, Canada
      Anapharm Montreal
    Dec 10, 2013

    HIV Lipodystrophy Trial in Boston (Growth hormone, Growth Hormone Releasing Hormone)

    Completed
    • HIV Lipodystrophy
    • Growth hormone
    • Growth Hormone Releasing Hormone
    • Boston, Massachusetts
      MGH
    Dec 6, 2013

    Aging, Mild Cognitive Impairment Trial in Seattle (TH9507 human growth hormone releasing hormone (GHRH))

    Completed
    • Aging
    • Mild Cognitive Impairment
    • TH9507 human growth hormone releasing hormone (GHRH)
    • Seattle, Washington
      University of Washington
    Dec 17, 2013

    HIV, Lipodystrophy Trial in Canada, United States (TH9507)

    Completed
    • HIV Infections
    • Lipodystrophy
    • Los Angeles, California
    • +41 more
    Nov 26, 2013

    Healthy Volunteers Trial in Boston (Growth Hormone Releasing Hormone (Tesamorelin))

    Completed
    • Healthy Volunteers
    • Growth Hormone Releasing Hormone (Tesamorelin)
    • Boston, Massachusetts
      MGH
    Apr 15, 2011

    Type 2 Diabetes Trial (TH9507)

    Completed
    • Type 2 Diabetes
    • (no location specified)
    Dec 20, 2010